Post-earnings recap
Reported
Wed, Nov 13, 2024
EPS actual
$-0.48
EPS est.
$-0.52
EPS surprise
+7.69%
1-day move
-5.04%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Enliven Therapeutics reported a wider-than-expected loss per share, but there was no revenue figure provided. The stock reacted negatively, dropping 5.04%, likely due to the lack of revenue information and guidance. Investors may be cautious as the company did not provide insights into future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.48 | N/A | +7.69% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, and the analysis is based solely on numerical results.